Status:
COMPLETED
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
To obtain further information on the tolerability of Atrovent® inhalets in the treatment of Chronic Obstructive Airways Disease under conditions of daily practice
Eligibility Criteria
Inclusion
- Primarily, Patients with chronic obstructive airways disease
- Only patients who had not been treated with Atrovent® in the last year were to be considered for inclusion
Exclusion
- \- Contraindications listed in the Instructions for Use/Summary of Product Characteristics for Atrovent® inhalets
Key Trial Info
Start Date :
December 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
374 Patients enrolled
Trial Details
Trial ID
NCT02238132
Start Date
December 1 1998
Last Update
September 12 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.